Myosin Therapeutics Inc. founded by Courtney A. Miller is a pioneering biopharmaceutical company based in Jupiter, Florida, that is making a significant impact on the biotechnology research industry. With $2.8M in seed funding from DeepWork Capital, Myosin Therapeutics is focused on developing cutting-edge medications that target cellular motor proteins, which are specialized molecular machines responsible for converting energy into mechanical work inside cells. Despite being an underexplored area of disease treatment, these molecular motors offer immense potential in treating a range of medical conditions, including cancer.

The company's mission is to address significant unmet medical needs, and its experienced team is dedicated to the leading discovery, optimization, and therapeutic development of the clinic. Myosin Therapeutics' platform is built around the discovery of novel small molecule modulators for the biologically important superfamily of molecular motors. With their innovative approach, Myosin Therapeutics is poised to transform the treatment of diseases that have thus far resisted traditional treatments, and they are well-positioned to lead the way in the biopharmaceutical industry.